BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rzeniewicz K, Sharma R. Systemic treatment of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease. World J Clin Oncol 2024; 15(11): 1394-1403 [PMID: 39582617 DOI: 10.5306/wjco.v15.i11.1394]
URL: https://www.wjgnet.com/2218-4333/full/v15/i11/1394.htm
Number Citing Articles
1
Xusheng Zhang, Wenyan Zhou, Bendong Chen, Qi Wang. Serum uric acid and the risk of MASLD in Americans: A cross-sectional study combined with Mendelian randomization and network toxicology analysisMedicine 2026; 105(1) doi: 10.1097/MD.0000000000046841
2
Hongkun Yin, Xusheng Zhang, Qi Wang. Trends and visualization analysis of research on MASLD-Related hepatocellular carcinoma: a bibliometric analysisDiscover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02858-9
3
Sen Wang, Ze-Kuan Xu, Hao Xu, Li Yang, Dian-Cai Zhang, Lin-Jun Wang, Feng-Yuan Li, Ji-Wei Wang, Hai-Tao Liu, Cheng-Jun Zhu, Ze-Tian Chen, Qing-Ya Li, Hong-Da Liu, Zheng Li, Zi-Chu Zhao, Yi-Gang Zhang, Yi-Fan Zou. Impact of non-alcoholic hepatic steatosis on prognosis and clinical outcomes in gastric cancer patients undergoing laparoscopic distal gastrectomyWorld Journal of Gastrointestinal Surgery 2025; 17(9): 106198 doi: 10.4240/wjgs.v17.i9.106198